SCHEMBL6609665

SCHEMBL6609665

Cc1ccc(S(=O)(=O)OCCCCCOc2nc3ccccc3n2C)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.47
GAA P10253 3/20 0.47
ALDH1A1 P00352 3/20 0.47
LMNA P02545 2/20 0.47
NPSR1 Q6W5P4 1/20 0.47
RAB9A P51151 4/20 0.44
NPC1 O15118 3/20 0.44
CYP24A1 Q07973 2/20 0.44
ALDH3A1 P30838 2/20 0.43
HTT P42858 5/20 0.43
SMN1; SMN2 Q16637 5/20 0.43
NR2F2 P24468 1/20 0.43
TP53 P04637 2/20 0.42
MAPT P10636 1/20 0.42
NOD1 Q9Y239 2/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CXCL8 P10145 1/20 0.42
NOD2 Q9HC29 1/20 0.42
TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6606550 0.84 HTT (0.41) HSD11B1GAAALDH1A1LMNANPSR1
SCHEMBL13189589 0.79 CA1 (0.53) HSD11B1GAAALDH1A1LMNANPSR1
SCHEMBL6605943 0.76 CA12 (0.44) GAAALDH1A1LMNANPSR1RAB9A
SCHEMBL8483813 0.75 ALDH1A1 (0.48) GAAALDH1A1CYP24A1SMN1; SMN2CA1
SCHEMBL4815560 0.75 ALDH1A1 (0.48) GAAALDH1A1CYP24A1SMN1; SMN2CA1
SCHEMBL4812770 0.75 ALDH1A1 (0.48) GAAALDH1A1CYP24A1SMN1; SMN2CA1
SCHEMBL4951882 0.75 ALDH1A1 (0.48) GAAALDH1A1CYP24A1SMN1; SMN2CA1
SCHEMBL8484861 0.75 ALDH1A1 (0.48) GAAALDH1A1CYP24A1SMN1; SMN2CA1
SCHEMBL11050599 0.75 ALDH1A1 (0.48) GAAALDH1A1CYP24A1SMN1; SMN2CA1
SCHEMBL4954181 0.75 ALDH1A1 (0.48) GAAALDH1A1CYP24A1SMN1; SMN2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6787561-B1 HYPERLIPIDEMIA, ARTERIOSCLEROSIS; ORAL ADMINISTRATION; SUPPRESSING THE FORMING OF MACROPHAGES FUJI PHOTO FILM CO., LTD. (JP) 2004-09-07 US disclosed
EP-1197493-B1 BENZIMIDAZOLE COMPOUNDS FUJI PHOTO FILM CO LTD (JP) 2004-03-24 EP disclosed
EP-1197493-A1 BENZIMIDAZOLE COMPOUNDS FUJI PHOTO FILM CO., LTD. (JP) 2002-04-17 EP disclosed